Corbus Pharmaceuticals Holdings (CRBP) EBIT (QoQ) (2013 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) EBIT (QoQ) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 105.87% |
| Jun 30, 2025 | 3.15% |
| Mar 31, 2025 | -1,210.96% |
| Dec 31, 2024 | -6.46% |
| Sep 30, 2024 | 18.94% |
| Jun 30, 2024 | 55.64% |
| Mar 31, 2024 | 110.17% |
| Dec 31, 2023 | -6.49% |
| Sep 30, 2023 | -15.86% |
| Jun 30, 2023 | 52.66% |
| Mar 31, 2023 | -60.20% |
| Dec 31, 2022 | -31.97% |
| Sep 30, 2022 | 33.70% |
| Jun 30, 2022 | -44.88% |
| Mar 31, 2022 | 14.81% |
| Dec 31, 2021 | 27.94% |
| Sep 30, 2021 | 16.92% |
| Jun 30, 2021 | -8.35% |
| Mar 31, 2021 | 25.94% |
| Dec 31, 2020 | 38.74% |